Status:
TERMINATED
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
Lead Sponsor:
BTG International Inc.
Collaborating Sponsors:
M.D. Anderson Cancer Center
Conditions:
Osteosarcoma
Eligibility:
All Genders
8-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to demonstrate whether use of glucarpidase facilitates administration of the next cycle of chemotherapy as scheduled and improves safety and tolerability of HDMTX given wi...
Eligibility Criteria
Inclusion
- osteosarcoma
- eligible to receive 2 sequential cycles of HDMTX-LV
Exclusion
- prior administration of glucarpidase
- progression of disease while on previous MTX treatment
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00634322
Start Date
October 1 2008
End Date
April 1 2009
Last Update
September 15 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.